Identification and analysis of the human CD160 promoter: Implication of a potential AML-1 binding site in promoter activation

Genes and Immunity

Volumn 10, Issue 7, 2009, Pages 616-623

  Schmitt, C ^a,b   Ghazi, B ^b   Bellier, F ^b   Bensussan, A ^a,b  

^a INSERM   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROTEIN CD160; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FREAC 4; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CHROMOSOME 1; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXON; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REPORTER GENE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; START CODON; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BINDING SITES; CHROMOSOMES, HUMAN, PAIR 1; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EXONS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; SEQUENCE ALIGNMENT; SOXF TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 70350287513     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.52     Document Type: Article

References (28)

1. Schmitt C, Ghazi B, Bensussan A. NK cells and surveillance in humans. Reprod Biomed Online 2008; 16: 192-201.
2. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-799.
3. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160: 3096-3100.
4. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274.
5. Gonzalez SV, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol 2006; 298: 121-138.
6. Bottino C, Biassoni R, Millo R, Moretta L, Moretta A. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum Immunol 2000; 61: 1-6.
7. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y et al Recognition of haemagglutinins on virus-induced cells by NKp46 activates lysis by human NK cells. Nature 2001; 409: 1055-1060.
8. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G et al. Inhibition of NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005; 6: 515-523.
9. Maiza H, Leca G, Mansur GI, Schiavon V, Boumsell L, Bensussan A. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 1993; 178: 1121-1126.
10. Anumanthan A, Bensussan A, Boumsell L, Christ AD, Blumberg RS, Voss SD et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cell, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998; 161: 2780-2790.
11. Agrawal SJ, Marquet J, Freeman GJ, Tawab A, Le Bouteiller P, Roth P et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 1999; 162: 1223-1226.
12. Bensussan A, Gluckman E, El Marsafy S, Schiavon V, Mansur GI, Dausset J et al. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci USA 1994; 91: 9136-9140.
13. Maeda M, Capenito C, Russell RC, Dasanjh J, Veinotte LL, Ohta H et al Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol 2005; 175: 4426-4432.
14. Abecassis S, Giustiniani J, Meyer N, Schiavon V, Ortonne N, Campillo JA et al. Identification of a novel CD160+CD4+ T-lymphocyte subset in the skin: A possible role for CD160 in skin inflammation. J Invest Dermatol 2007; 127: 1161-1166.
15. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 2008; 9: 176-185.
16. Fons P, Chabot S, Cartwright JE, Lenfant F, L'Faqihi F, Giustiniani J et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006; 108: 2608-2615.
17. Giustiniani J, Marie-Cardine A, Bensussan A. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol 2007; 178: 1293-1300.
18. Kurokawa M, Hirai H. Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Cancer Sci 2003; 94: 841-846.
19. Giustiniani J, Bensussan A, Marie-Cardine A. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), an unique activating receptor selectively expressed upon human NK cell activation. J Immunol 2009; 182: 63-71.
20. Scherf M, Klingenhoff A, Werner T. Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: A novel context analysis approach. J Mol Biol 2000; 297: 599-606.
21. Ernstsson S, Pierrou S, Hulander M, Cederberg A, Hellqvist M, Carlsson P et al. Characterization of the human forkhead gene FREAC-4. Evidence for regulation by Wilms' tumor suppressor gene (WT-1) and p53. J Biol Chem 1996; 271: 21094-21099.
22. Melichar HJ, Narayan K, Der SD, Hiraoka Y, Gardiol N, Jeannet G et al Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 2007; 315: 230-233.
23. Kim I, Saunder TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 2007; 130: 470-483.
24. Kurokawa M. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int J Hematol 2006; 84: 136-142.
25. Ohno S, Sato T, Kohu K, Okumura K, Satake M, Habu S. Runx proteins are involved in the regulation of CD122, Ly49 and IFN-gamma expression during NK cell differentiation. Int Immunol 2008; 20: 71-79.
26. Trompeter HI, Gómez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C et al. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol 2005; 174: 4135-4143.
27. Wargnier A, Legros-Maida S, Bosselut R, Bourge JF, Lafaurie C, Ghysdael CJ et al. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci USA 1995; 92: 6930-6934.
28. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T et al FoxP3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446: 685-689.